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Abstract
Alzheimer’s disease is a degenerative disease found in many aging adults. The presence
of amyloid precursor protein (APP) is an early indicator of the onset of Alzheimer’s, primarily in
memory-related brain regions like the hippocampus. Hormones accompanying pregnancy, such
as estrogen, may provide the female brain with protection against neurodegeneration and
deposits of APP. The present study will compare concentrations of APP in the brains of parous
and nulliparous animals and examine the interaction of APP with estrogen receptor beta (ER).
Young and aged animals will also be compared to determine any early effects of APP or ER.
It is proposed that because of the neuroprotective effects of preganacy, the parous animals will
have lower concentrations of APP and higher concentrations of ER.
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Maternal Experience and Alzheimer’s Disease:
Degenerative Differences in the Female Rat
Alzheimer’s disease is quickly becoming one of the most prevalent and devastating
afflictions of today’s aging population. Alzheimer’s disease is the fourth leading cause of death
in Western nations, and it is estimated that approximately 24 million people worldwide suffer
from Alzheimer’s-related dementia (Miller, McLoughlin, Kwok-Fai, Tennant, & Rogelj, 2006).
There is no cure or effective treatment currently available for Alzheimer’s disease, but given its
frequent occurrence in older adults, the need for treatment is becoming more and more
pronounced. In addition to seeking treatment for Alzheimer’s, scientists are still working to
understand the intricate details of the complex pathology of this disease (Kar, Slowikowski,
Westaway, & Mount, 2004).
Alzheimer’s disease is most distinctly characterized by neural plaques and neurofibrillary
tangles, which both lead to eventual lesions in the brain, as well as a decrease in number of
neurons and functional synaptic connections. Therefore, neurons are unable to efficiently pass
on messages, and cognitive functioning begins to decline (Stephan, Laroche, & Davis, 2001).
The development of these degenerative features is linked to deposits of amyloid precursor
protein (APP) in the brain, especially in regions associated with memory such as the
hippocampus. High concentrations of APP deposits are often found extremely early in the
pathogenesis of the disease, even before specific Alzheimer’s symptoms emerge (Stephan,
Laroche, & Davis, 2001). Most notably, -amyloid peptide (A) is derived from the APP
deposits in the brain. The A acts as the core for the formation of neural plaques (Kar et al.,
2004).
The role of A and APP in the pathogenesis of Alzheimer’s disease has been evaluated in
many studies of animal models. Stephan, Laroche, and Davis (2001) found that rats injected
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with small amounts of A experienced a significantly accelerated development of neural
plaques. The injected animals also performed poorly on cognitive tasks, made more behavioral
mistakes in navigation, and made a greater number of errors on a working memory task than the
non-injected control group. These decreases in memory performance indicate that the presence
of Alzheimer’s-related proteins in the brain lead to both negative behavioral modifications and
disruptions in underlying neuroanatomy.

APP can have detrimental effects on the strength and

speed of neuronal firing. In a mouse model of Alzheimer’s, results indicated that hippocampal
neurons lacking in APP had a higher frequency and strength of synaptic transmissions, and there
were more functional neurons in the areas of the brain without APP (Priller, Bauer, Mitteregger,
Krebs, Kretzschmar, & Herms, 2006). Once APP and A effectively deposit the neural tangles
and plaques, the target regions of the brain start to lose neurons and functional synapses,
resulting in the beginnings of the slow cognitive degeneration associated with Alzheimer’s
disease (Kar et al., 2004).
Sex Differences and Hormones
Alzheimer’s disease is more prevalent in women than in men. This sex difference can be
attributed to an overall longer female lifespan and differences in the duration of the disease;
women with Alzheimer’s tend to live longer with the disease than men (Baum, 2005). The body
may also provide some natural defenses against the effects of Alzheimer’s. Specifically,
hormones may play a mediating role in the development and progression of the disease. It has
been suggested that testosterone may protect men from Alzheimer’s disease, while estrogen may
have similar protective effects for women (Baum, 2005).
Studies on hormone replacement therapy have confirmed the beneficial effects of female
hormones like estrogen on the pathogenesis of Alzheimer’s disease. Henderson, Benke, and
Greene (2005) found that a hormone therapy regimen including estrogen might reduce the risk of
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developing early onset Alzheimer’s. It was also concluded that the hormone therapy must be
administered at a certain critical time period, during the early stages of postmenopausal
symptoms, for protective effects against Alzheimer’s to be executed. Beginning a hormone
therapy regimen years after the onset of menopause and the loss of endogenous estrogen is too
late, and the beneficial effects that result from earlier hormone administration will not occur
(Baum, 2005). Generally, hormone replacement therapy exhibits a ‘healthy cell bias,’ in which
neurons that are healthy during administration will experience the benefits of therapy, while
hormones will cause further damage in unhealthy neurons (Brann, Dhandapani, Wakade,
Mahesh, & Khan, 2007). It is also important to consider dosage when administering hormone
replacement therapy. Baum (2005) reported an inverted U-shaped pattern in the effectiveness of
hormone dosages; a small dosage did not show any effects and a large dosage could have toxic
and harmful effects. An excessive administration of exogenous estrogen can disrupt the body’s
natural fluctuations of hormones, which can actually have detrimental effects on the functioning
of the brain (Marriott & Wenk, 2004). Moderate amounts of hormone replacement therapy that
more closely mimic the body’s natural cycle may provide the best protection against the
degeneration of Alzheimer’s disease (Marriott & Wenk, 2004).
The Role of Estrogen Receptors
Estrogen is a female reproductive hormone, traditionally associated with gender
differentiation during the developmental period and increased synaptic plasticity during puberty
and the ovarian cycle. More recently, estrogen has been implicated in playing a role in vital
actions of the brain, including the release of neurotransmitters, electrical excitability, and
synaptic function (Genazzani, Pluchino, Luisi, & Luisi, 2007). The positive role of estrogen in
neuroaction has made it a focus of recent research on the prevention of neurodegenerative
diseases. Estrogen depletion in the aging brain may be an early risk factor for Alzheimer’s
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disease, and a continued presence of estrogen in the brain may preserve specific areas in the
brain targeted by disease pathology (Brann et al., 2007). Although estrogen-based hormone
replacement therapy has been linked to reduced risk of Alzheimer’s onset, the side effects have
made the therapy controversial. The actions of the therapy are beneficial in the brain, but can
have detrimental impacts on peripheral tissues, including an increased risk of breast and uterine
cancer (Carroll & Pike, in press). Because of these harmful effects, research on estrogen
therapies has focused on making treatments more specific to the areas of the brain associated
with neurodegeneration.
One target-specific focus of research has involved the differentiation between two
different estrogen receptors: estrogen receptor alpha (ER) and estrogen receptor beta (ER).
Both receptors have been linked to neuroprotection in the brain, especially in learning and
memory-related areas (Genazzani et al., 2007). ER and ER are both present in the
hippocampus, and deposits of Alzheimer’s-related proteins are regulated through each of these
receptors (Brann et al., 2007). However, the different mechanisms of ER and ER are not fully
understood. Overall, the actions of estraidol, a clinical form of estrogen, are found to be
predominantly dependent on ER, indicating that it is the primary estrogen receptor (Carroll &
Pike, in press).
Research has shown that ER, a more recently discovered receptor, might also play a
primary role in estrogen regulation in the brain, especially in association with Alzheimer’s
pathology. ER is closely associated with learning and memory because it is the predominant
type of estrogen receptor found in the hippocampus (Genazzani et al., 2007). Because of its
increased presence in the hippocampus, hormone therapy that is ER specific might have
especially beneficial effects in the brain (Wang, Irwin, & Brinton, 2006). Research by Forsell,
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Enmark, Axelman, Blomberg, Wahlund, Gustafsson, et al. (2001) further linked ER and
Alzheimer’s by confirming that a mutation in the ER gene might increase susceptibility to
Alzheimer’s disease. Given this recent research on its presence in the hippocampus and
association with Alzheimer’s disease, the present study will focus on the expression of ER in
the brain.
Maternal Experience
The benefits of the natural hormonal changes associated with the female reproductive
experience are well established. Motherhood leads to improvements in learning and memory,
both of which are functions of the hippocampus. Oxytocin, another hormone associated with
reproduction, also enhances neural functioning and potentiation of neural messages (Pawluski,
Walker, & Glaea, 2006). Pregnant female rats demonstrated better performance on tests of
spatial memory than virgin rats, which can be attributed to the elevated and relatively stable
levels of estrogen present in the body during pregnancy (Galea, Ormerod, Sampath, Kostaras,
Wilkie, & Phelps, 2000). Galea et al. (2000) also established that pregnant rats spent more time
in the target quadrant of the water maze and traveled shorter distances to the reward than
nonpregnant animals, demonstrating the positive effects of pregnancy on learning and memory.
In addition to hormonal changes, maternal animals must respond to a large number of
novel stimuli as a result of exposure to pups. Suddenly, new mothers find that they are
responsible for the survival of their offspring (Love, Torrey, Glasper, DeVries, Lambert, &
Kinsley, 2005). They must quickly acquire new skills, such as improving their hunting abilities,
so that they can obtain food for themselves as well as their new pups. New mothers must learn
to forage and recall the spatial location of food in an effort to spend less time away from their
offspring (Love et al., 2005). The first pregnancy is therefore critical, as the female brain begins
to change in response to new hormone levels and a range of sensory stimuli from the pups. The
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maternal rat must make her own modifications and obtain new skills to ensure the survival of her
offspring, without any previous experience or knowledge in this area (Pawluski et al., 2006).
Subsequent pregnancies can increase the benefits of initial hormone and pup exposure. While
primiparous (single reproduction) animals outperformed nulliparous (no reproduction) animals
on tests of learning and memory, multiparous (more than one reproduction) animals often
performed better than both groups (Gatewood, Morgan, Eaton, McNamara, Stevens, & Kinsley,
2005). Therefore, repeated exposure to reproductive hormones and offspring can lead to a
further enhancement in neural functioning and memory.
The present study looks to extend the findings of Gatewood et al. (2005) that the paired
exposure to both pups and the natural hormonal changes of the female reproductive experience
preserves the aging brain from degeneration and provides neuroprotection against memory
declines. Parous animals have lower levels of amyloid precursor protein in their brains, and
multiparous animals have significantly less of the protein deposited in their brains than
primiparous animals (Gatewood, 2005). These results suggest that the protection provided by
maternal experience can extend specifically to defense against the risks of Alzheimer’s disease.
Given that the results of hormone replacement studies have supported the benefits of moderate
dosages that mimic the actual female hormone cycle, it is possible that the natural exposure to
female reproductive hormones provides an effective barrier against the onset of Alzheimer’s,
even at a relatively young age (Marriott & Wenk, 2004). It is also possible that moderate
dosages of hormone replacement therapy and natural reproductive hormone levels have equally
beneficial effects (Love et al., 2005).
A preliminary study in female rats did indicate higher concentrations of APP in
nulliparous animals than primiparous animals, which were aligned with the findings of previous
research (Gatewood et al., 2005). An immunofluorescent investigation of the expression of APP
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in the female hippocampus showed that primiparous animals had a lower concentration of APP
in the hippocampal region of their brains than age-matched nulliparous animals. While it is
expected that maternal experience will offer some protection against the onset of
neurodegeneration, the present study looks to specifically examine the expression of ER in the
female rat brain. An understanding of how the deposits of ER and APP interact and are
expressed together can give some further indication to the specific protective mechanisms of
pregnancy hormones in the brain.
The current study will expand upon past findings investigating the early signs of
neurodegeneration in younger rats. While past research has focused on the presence of
Alzheimer’s-related declines in aged animals, more research in younger animal models will
indicate the effects of APP and memory decline early in life. Priller et al. (2006) found that in
animals lacking APP, the enhancements of neuron and synapse functioning were more
pronounced in young mice, aged three weeks, than older mice, aged 11 months. Studies
involving the administration of degenerative protein have also supported their quick and early
action. In animals injected with A, collections of amyloid protein and neuron loss were seen
around injection sites in as little as seven weeks (Stephan et al., 2001). Given the support of
early administration of therapeutic remedies like hormone replacement therapy, it is important to
identify the early progression of the disease to effectively stop the first signs of Alzheimer’s
pathology.
The present study will investigate the effects of maternal experience, its accompanying
hormones, and its novel stimuli on the emergence of neuroanatomical changes related to
Alzheimer’s disease in young and old female rats. It is expected that our findings will replicate
past research that deposits of APP increase with age, while the presence of estrogen receptors
decrease with age (Priller et al., 2006; Brann et al., 2007). It is expected that these neural
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differences will be seen predominantly in the hippocampus, a region of the brain essential for
memory. Specifically, the current study will focus its investigation on the CA1 region of the
hippocampus, an area of neural density and a high concentration of ER receptors (Carroll &
Pike, in press).
Hypotheses
1. It is hypothesized that primiparous animals will have less APP than nulliparous animals, as
measured by the area of APP expression.
2. It is hypothesized that younger animals will have less APP than older animals, as measured by
the area of APP expression.
2a. It is hypothesized that old primiparous animals will have less APP than old nulliparous
animals.
2b. It is hypothesized that old primiparous animals will have more APP than young
primiparous and young nulliparous animals.
2c. It is hypothesized that old nulliparous animals will have more APP than young
primiparous and young nulliparous animals.
2d. It is hypothesized that young primiparous animals will have less APP than young
nulliparous animals.
3. It is hypothesized that primiparous animals will have more ER than nulliparous animals, as
measured by the area of ER expression.
4. It is hypothesized that younger animals will have more ER than older animals, as measured
by the area of ER expression.
4a. It is hypothesized that old primiparous animals will have more ER than old nulliparous
animals.
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4b. It is hypothesized that old primiparous animals will have less ER than young primiparous
and young nulliparous animals.
4c. It is hypothesized that old nulliparous animals will have less ER than young primiparous
and young nulliparous animals.
4c. It is hypothesized that young primiparous animals will have more ER than young
nulliparous animals.
Method
Animals
The animals used in the present study were six female rats, and they were ordered from
Zivic-Miller Laboratories, Inc. The animals were housed in the University of Richmond Animal
Facility. Each animal was housed individually in a 25 cm  40 cm  25 cm cage with corncob
bedding, and food and water was available ad libitum in the home cage. The animals differed
only in their ages and reproductive experience. Two of the rats were 12 months of age at the
time of perfusion, and four of the animals were four months of age at the time of perfusion. The
older animals were perfused at the age of approximately 12 months because it is a time when
potentially degenerative neuroanatomy is expected to be observed, yet the animals have not fully
reached old age (Gatewood et al., 2005). The younger animals were perfused at the age of four
months because it is an early time in the developmental period of the rat when early signs of
neurodegeneration are expected to emerge (Priller et al., 2006). Of the older rats, one was a
primiparous animal (having one pregnancy) and the other was a nulliparous animal (having no
pregnancies). Two of the younger rats were primiparous, while the other two were nulliparous.
The older parous animal was given a 21-day postpartum experience with her offspring before the
pups were weaned, and the younger parous animals were given a 14-day postpartum experience.
The parous and nulliparous animals were exposed to identical living conditions, and the home
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cages of all of the animals were housed in the same room so as to be exposed to the same light
and dark schedule.
Tissue Preparation
The animals were exposed to carbon dioxide gas and sacrificed by an overdose of sodium
pentobarbital. The animals were then perfused with both PBS and 4% paraformaldehyde (PF),
and their brains were surgically removed. The dissected brains were immersed in PF for
approximately five hours, and then switched to a solution of 30% PBS sucrose for two days. The
sucrose was switched after the first day.
The brains were sectioned for the area of interest, the anterior region of the hippocampus,
with the aid of an atlas (Paxinos & Watson, 1998). That section of the brain was then sliced by a
cryostat set at -18 °C into sections that were 40  in thickness. Approximately 48 slices were cut
for each animal, and placed in groups of four into 12-well culture dishes filled with TBS. After
several initial TBS washes, the sections were immersed in a primary antibody cocktail overnight
at 4 °C. The primary antibody cocktail was composed of a rabbit anti-amyloid precursor protein
polyclonal antibody (Invitrogen 51-2700) and a goat anti-ER polyclonal antibody (Santa Cruz
Biotechnology sc-6821). The anti-APP primary antibody was used at a dilution of 1:500 (2
g/ml), and the anti-ER primary antibody was used at a dilution of 1:200 (5 g/ml). As a
negative control measure to check for nonspecific staining, two wells per tray were not exposed
to the overnight primary antibody incubation, although all of the other steps of the protocol were
followed for these tissue sections. The second day, after more TBS washes, the sections were
immersed in the secondary antibody cocktail for two hours at 4 °C. The secondary cocktail was
compiled of a goat anti-rabbit Alexa Fluor 488 secondary antibody (Invitrogen A11070) and a
rabbit anti-goat Alexa Fluor 594 secondary antibody (Invitrogen A21223). Both secondary
antibodies were used at a dilution of 1:400 (2.5 g/ml). During the secondary antibody wash, the
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culture trays were covered in aluminum foil to prevent exposure of the sensitive fluorescent
antibodies to light. (see Appendix A for immunofluorescent protocol).
After the completion of staining, the tissue sections were mounted onto gelatin subbed
slides and allowed to dry overnight. The slides were covered in foil to minimize light exposure.
Once they were dry, the sections were coverslipped with Prolong Gold antifade reagent with
DAPI (Invitrogen P36935). Prolong Gold preserves the tissue and fluorescent signal, while the
DAPI is used as a marker of cell bodies because it binds to nuclear chromosomes and emits a
blue fluorescent stain of DNA (Invitrogen, 2008).
Tissue Analysis
The tissue sections were analyzed with a Zeiss Imager.Z1 microscope. The program
AxioVision (release 4.6.1) was also used to analyze images and quantify protein expression in
the tissue sections. The CA1 of the hippocampus was initially identified at 5 magnification,
and an image of the CA1 for each tissue section was captured at 40 magnification. Each image
captured a 220.4 m  170 m portion of the CA1. A merged image of multiple fluorescent
channels was captured to show the combined presence of the green APP fluorescence, the red
ER fluorescence, and the blue DAPI fluorescence (see Figures B1-F1).
As part of the AxioVision software, Program Wizard was used to quantify the area of
APP and ER fluorescent expression in each tissue section. First, the merged images were
separated, and the green APP stain and red ER stain were quantified separately. The program
selected areas of cell bodies expressing an optimal amount of fluorescent stain and calculated the
total summed area of the amount of stain per image. The areas of expression were calculated in
m2, and the means of APP and ER expression were calculated for each animal.
Results
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Amyloid Precursor Protein Analysis
Primiparous animals had less APP expression (M = 2069.76 m2, SD = 1623.86) than
nulliparous animals (M = 4236.30 m2, SD = 1229.70). An one-way ANOVA was run and did
not indicate a significant difference, F(1,4) = 3.39, p = 0.14 (see Table H1).
Young animals had less APP expression (M = 2372.65 m2, SD = 1510.64) than older
animals (M = 4713.79 m2, SD = 1088.58). An one-way ANOVA was run and did not indicate a
significant difference F(1,4) = 3.64, p = 0.13 (see Table I1).
To further determine differences in APP expression, a 2  2 between-subjects ANOVA
was run. The old primiparous animal had more APP expression (M = 3944.04 m2, SD = 0.00)
than the young primiparous animals (M = 1132.62 m2, SD = 66.77). The old nulliparous animal
also had more APP expression (M = 5483.53 m2, SD = 0.00) than the young nulliparous animal
(M = 3612.68 m2, SD = 831.22). A significant main effect of age was found, F(1,2) = 21.02, p
< 0.05, and a marginally significant main effect of maternal experience was found, F(1, 2) =
15.49, p = 0.06. There was not a significant interaction of age and maternal experience, F(1,2) =
0.85, p = 0.45 (see Table J1).
Estrogen Receptor Beta Analysis
Primiparous animals had more ER expression (M = 1200.47 m2, SD = 656.96) than
nulliparous animals (M = 331.80 m2, SD = 215.19). An one-way ANOVA was run and did
indicate a significant difference, F(1,4) = 10.10, p < 0.05 (see Table K1).
Young animals had less ER expression (M = 719.90 m2, SD = 584.06) than older
animals (M = 1458.61 m2, SD = 1272.43). An one-way ANOVA was run and did not indicate a
significant difference F(1,4) = 1.10, p = 0.35 (see Table L1).
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To further determine differences in ER expression, a 2  2 between-subjects ANOVA
was run. The old primiparous animal had more ER expression (M = 2358.35 m2, SD = 0.00)
than the young primiparous animals (M = 1221.53 m2, SD = 40.04). The old nulliparous animal
also had more ER expression (M = 558.86 m2, SD = 0.00) than the young nulliparous animal
(M = 218.28 m2, SD = 123.61). A significant main effect of age was found, F(1,2) = 86.19, p <
0.05, and a significant main effect of maternal experience was found, F(1, 2) = 310.19, p < 0.05.
There was also a significant interaction of age and maternal experience, F(1,2) = 25.04, p < 0.05
(see Table M1).
Discussion
The present study supported the hypothesis that primiparous animals would have
significantly higher levels of ER expression than nulliparous animals. The hypothesis that
primiparous animals would have less APP than nulliparous animals was not supported. Also, the
hypotheses that younger animals would have less APP than older animals and that younger
animals would have more ER than older animals were not supported. However, there was a
main effect of age on APP expression and main effects of age and maternal experience on ER
expression. Finally, an interaction of age and maternal experience on ER expression was also
established. These trends in the data might have interesting implications for the study of
Alzheimer’s disease and potential therapeutic targets.
One of the most interesting trends in the data was that primiparous animals did have
lower mean levels of APP expression in the CA1 of the hippocampus than nulliparous animals.
These findings indicate that maternal experience might offer some protection against the
depositing of APP in the brain. Since the present study investigated only naturally-occurring,
baseline levels of APP and ER, these results support past findings that moderate dosages of
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hormone replacement therapy that mimic the body’s natural levels might have the best
neuroprotective effects (Marriott & Wenk, 2004). However, it is important to note that there was
not an overall significant difference in APP expression between parous and nulliparous animals.
While pregnancy hormones might offer some neurprotection, the results of the present study
indicate that there are other factors influencing the pathogenesis of Alzheimer’s. Hormone
replacement therapy might not be the best treatment option in all cases. Potential detrimental
effects of hormone replacement therapy have been established and were laid forth in the
Women’s Health Initiative Study, including an increased risk of dementia and cancer in
peripheral tissues (Baum, 2005).
The present study did find a significant difference in the expression of ER. Primiparous
animals had more ER than nulliparous animals. The combined presence of ER and APP in the
tissue sections examined indicates that ER might have a role in offering neuroprotection.
However, more research needs to be completed on the specific mechanisms of ER, especially in
contrast to what is known about the mechanisms of ER. It is possible that one type of receptor
offers a higher degree of neuroprotection than the other type. Therapies that specifically target
the most beneficial receptor type could be particularly effective in refining the actions of
hormone replacement therapy and combating the onset of Alzheimer’s disease (Carroll & Pike,
in press).
Another interesting trend in the present study was the age differences found in measured
area of APP expression. Higher mean areas of APP were found in older animals. There was a
significant main effect of age and APP expression, but the overall age difference was not found
to be statistically significant, indicating that there was also a presence of APP in the hippocampal
regions of the younger animals. This finding supports past research that the onset of Alzheimer’s
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disease symptoms can begin relatively early in the lifespan, and that the effects of the changes in
neuroanatomy can begin to take their toll at a young age (Stephan et al., 2001).
The trend seen in age differences in ER expression was also found, although this trend
opposed the proposed hypothesis. Overall, younger animals had lower means of ER expression
than older animals, and a significant main effect of maternal experience and ER expression was
established. These results do not support past findings of a decline in estrogen receptor
expression with age (Brann et al., 2007). In contrast, the present results suggest that ER levels
might remain relatively stable or even increase across the lifespan. These findings have
implications in considering dosage levels for hormone replacement administration, especially in
older women. In order to maintain an effective moderate dose, the changes in baseline hormone
levels that come with age need to be further understood.
It is important to note that the trend of more expression of ER may be attributed to the
fact that the older and younger primiparous animals had differing lengths of postpartum periods
with their offspring. Post-pregnancy events, including sensory exposure to pups and lactation,
have been found to contribute to the increased neural plasticity accompanying motherhood,
above and beyond the effects of the pregnancy hormones alone (Love et al., 2005). Since the
older animals had a longer postpartum period with their pups, it is possible that the additional
week of offspring sensory exposure led to further neuroanatomical changes and allowed them to
maintain higher levels of ER expression.
A primary limitation of the present study is the small sample size. Only six animals were
investigated, and the older age group only consisted of two animals. It would be important to
replicate the current findings with a larger sample of animals. Another limitation in the present
study was the limited area of the brain examined. While the CA1 of the hippocampus has been
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found to be essential for memory related-processes, in addition to being a main target of
Alzheimer’s pathogenesis, it is possible that other areas of the brain play an equally important
role in the progression of the disease. It would be interesting to study other areas of the brain
linked to learning and memory, such as the amygdala, or even other regions within the
hippocampus. For example, the dentate gyrus has also been found to be a site of high neural
density and protein expression that might also be a target of Alzheimer’s pathogenesis
(Gatewood et al., 2005).
Future research could expand upon the present study by including a behavioral task, in
addition to brain analysis. Studies have indicated that overall, parous animals outperform
nulliparous animals on learning and memory-related tasks (Love et al., 2005; Galea et al., 2000;
Pawluski et al., 2006). Additionally, animal models injected with APP have demonstrated
decreased performances in working-memory tasks (Stephan et al., 2001). It would be interesting
to include a behavioral component to investigate the combined effects of maternal experience as
well as Alzheimer’s-related protein deposits in the brain on behavioral performance. This
research would result in a further connection between behavioral performance and underlying
neuroanatomical structure.
The findings of the present study have implications for the further study of Alzheimer’s
disease pathology and potential sites of therapeutic action. The present findings indicate a
complex and dynamic interaction between deposits of APP and the presence of ER. This
relationship that is seen in even natural, baseline levels indicates the further complications that
can be brought on by additional hormone administration. Future research needs to be continued
to find sites of action and optimal doses for exposure to exogenous estrogen. An effective
administration of hormones would result in neuroprotection against the onset of degenerative
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proteins, without making the body susceptible to potentially the potentially detrimental effects of
too much hormone exposure.
Finally, the present study has implications for the elucidation of the complex aspects of
Alzheimer’s pathology. Specifically, the results indicate that the disease might have a unique
and specific progression in the female brain because of the differential effects of sex hormones
on neuroanatomy. Since Alzheimer’s disease is more prevalent in women, it is important to
further understand the particular ways in which the pathogenesis of the disease attacks the female
brain. Further understanding of the actions of Alzheimer’s in the brain and the protective impact
of female hormones might introduce novel sites of therapeutic action that could moderate the
devastation of this neurodegenerative disease.

Maternal Experience

20

Works Cited
Baum, L. W. (2005). Sex, hormones, and Alzheimer’s disease. Journal of Gerontology,
60A(6), 736-743.
Brann, D. W., Dhandapani, K., Mahesh, V. B., & Khan, M. M. (2007). Neurotropic and
neuroprotective actions of estrogen: Basic mechanisms and clinical implications.
Steroids, 72(5), 381-405.
Carroll, J. C. & Pike, C. J. (in press). Selective estrogen receptor modulators differentially
regulate Alzheimer’s-like changes in female 3XTg-AD mice. Endocrinology.
Forsell, C., Enmark, E., Axelman, K., Blomberg, M., Wahlund, L., Gustafsson, J., et al. (2001).
Investigations of CA repeat in the oestrogen receptor  genes in patients with
Alzheimer’s disease. European Journal of Human Genetics, 9, 802-804.
Galea, L. A. M., Ormerod, B. K., Sampath, S., Kostaras, X., Wilkie, D. M., & Phelps, M. T.
(2000). Spatial working memory and hippocampal size across pregnancy in rats.
Hormones and Behavior, 37, 86-95.
Gatewood, J. D., Morgan, M. D., Eaton, M., McNamara, I. M., Stevens, L. F., Kinsley, C. H.,
et al. (2005). Motherhood mitigates aging-related decrements on learning and memory
and positively affects brain aging in the rat. Brain Research Bulletin, 66(2), 91-98.
Henderson, V. W., Benke, K. S., & Greene, R. C. (2005). Postmenopausal hormone therapy
and Alzheimer’s disease risk: Interaction with age. Journal of Neurology,
Neurosurgery, and Psychiatry, 76(1), 103-105.
Invitrogen. (2008). ProLong Gold antifade reagent with DAPI. Retrieved April 4, 2008 from
http://products.invitrogen.com.
Kar, S., Slowikowski, S. P. M., Westaway, D., & Mount, H. T. J. (2004). Interactions between
ß-amyloid and central cholinergic neurons: implications for Alzheimer’s disease.

Maternal Experience

21

Journal of Psychiatry and Neuroscience, 29(6), 427-441.
Love, G., Torrey, N., Glasper, E. R., DeVries, A. C., Lambert, K. G., Kinsley, C. H., et al.
(2005). Maternal experience produces long-lasting behavioral modifications in the
rat. Behavioral Neuroscience, 119(4), 1084-1096.
Marriott, L. K. & Wenk, G. L. (2004). Neurobiological consequences of long-term estrogen
therapy. Current Directions in Psychological Science, 13(5), 173-176.
Miller, C. C. J., McLoughlin, D. M., Kwok-Fai, L., Tennant, M. E. & Rogelj, B. (2006).
The X11 proteins, Aß production, and Alzheimer’s disease. Trends in
Neuroscience, 29(5), 280-285.
Pawluski, J. L., Walker, S. K., & Galea, L. A. M. (2006). Reproductive experience
differentially affects spatial reference and working memory performance in the mother.
Hormones and Behavior, 49, 143-149.
Paxinos, G. & Watson, C. (1998). The rat brain in stereotaxic coordinates (4th ed.). San Diego,
CA: Academic Press.
Priller, C., Bauer, T., Mitteregger, G., Krebs, B., Kretzschmar, H. A., & Herms, J. (2006).
Synapse formation and function is modulated by the amyloid precursor protein.
Journal of Neuroscience, 26(27), 7212-7221.
Stephan, A., Laroche, S., & Davis, S. (2001). Generation of aggregated ß-amyloid in the rat
hippocampus impairs synaptic transmission and plasticity and causes memory deficits.
Journal of Neuroscience, 21(15), 5703-5714.
Wang, J. M., Irwin, R. W., & Brinton, R. Z. (2006). Activation of estrogen receptor

and

estrogen receptor  decreases apolipoprotein E expression in hippocampus in vitro and
in vivo. Proceedings of the National Academy of Sciences of the United States of
America, 103(45), 16983-16988.

Maternal Experience
Appendix A
Immunofluorescent Staining Protocol
TBS (1L)
900 ml dH20
6.05 g Tris base
9 g NaCl
TBS ++ (500 ml)
15 ml 3% normal goat serum
1.25 ml 10% Triton
500 ml TBS
Staining: Day One
5 min TBS
5 min TBS
5 min TBS
60 min TBS ++
Overnight in 1º Ab diluted in TBS++ (keep at 4 ºC)
Staining: Day Two
15 min TBS
15 min TBS
15 min TBS++
***The rest of the steps should be done with absolute minimal exposure to light
120 min 2º Ab diluted in TBS ++ (keep at 4 ºC)
5 min TBS
5 min TBS
Tissue Preparation: Day Three
Allow mounted slides to dry overnight, then coverslip with Prolong Gold with DAPI
***Allow coverslipped slides to dry for three-five days before placing in a slide box
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Figure B1
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Figure C1
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Figure D1
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Figure E1
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Figure F1
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Appendix G
Figure Captions
Figure B1. Preliminary immunofluorescent stain for amyloid precursor protein (green) and
DAPI (blue) in CA1 of an old primiparous animal, 40 magnification.
Figure C1. Immunofluorescent stain for amyloid precursor protein (green), estrogen receptorbeta (red), and DAPI (blue) in CA1 of an old primiparous animal, 40 magnification.
Figure D1. Immunofluorescent stain for amyloid precursor protein (green), estrogen receptorbeta (red), and DAPI (blue) in CA1 of an old nulliparous animal, 40 magnification.
Figure E1. Immunofluorescent stain for amyloid precursor protein (green), estrogen receptorbeta (red), and DAPI (blue) in CA1 of a young primiparous animal, 40 magnification.
Figure F1. Immunofluorescent stain for amyloid precursor protein (green), estrogen receptorbeta (red), and DAPI (blue) in CA1 of a young nulliparous animal, 40 magnification.
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Table H1
Mean Levels of Amyloid Precursor Protein Expression in Animals with Different Maternal
Experience
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Table I1
Mean Levels of Amyloid Precursor Protein Expression in Animals from Different Age Groups
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Table J1
Mean Levels of Amyloid Precursor Protein Expression in Animals from Different Age Groups
with Different Maternal Experience
**
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*
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*
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*
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0
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Nulliparous

Age group & maternal experience

* indicates a significant main effect of age at the 0.05 level
** indicates a marginally significant effect of maternal experience

31

Maternal Experience
Appendix K
Table K1
Mean Levels of Estrogen Receptor Beta Expression in Animals with Different Maternal
Experience
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*indicates a significant difference at the 0.05 level
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Table L1
Mean Levels of Estrogen Receptor Beta Expression in Animals from Different Age Groups
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Appendix M
Table M1
Mean Levels of Estrogen Receptor Beta Expression in Animals from Different Age Groups with
Different Maternal Experience
**
*
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ER_ expression (m2)
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*
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*

**
*
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Young

Primiparous

***
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Nulliparous

Age group and maternal experience

* indicates a significant main effect of age at the 0.05 level
** indicates a significant effect of maternal experience at the 0.05
***indicates a significant interaction of age and maternal experience at the 0.05 level

